10.23664/H3A.CLINICAL.AND.POPULATION.DATASET.2021
Sobngwi, Eugene
University of Yaoundé 1
Balde, Naby
CHU Donka, University of Conakry
Nyirenda, Moffat
Malawi‐Liverpool-Wellcome Trust Unit, Blantyre
Heyderman, Robert
Malawi‐Liverpool-Wellcome Trust Unit, Blantyre
Oli, John
University of Nigeria Teaching Hospital, Enugu
Adebamowo, Clement
Institute of Human Virology, Abuja
Levitt, Naomi
Faculty of Health Sciences, University of Cape Town
Motala†, Ayesha
Nelson R Mandela School of Medicine, University of KwaZulu‐Natal, Durban
Mayige, Mary
National Institute for Medical Research, Dar es Salaam
Kapiga, Saidi
Mwanza Intervention Trials Unit/NIMR Tanzania
Kaleebu, Pontiano
MRC/UVRI Unit Uganda
Sandhu, Manjinder
University of Cambridge
Smeeth, Liam
London School of Hygiene and Tropical Medicine
McCarthy, Mark
Wellcome Trust Centre for Human Genetics; MRC Centre for Global Health Genomics, Oxford University
Rotimi, Charles
National Human Genome Research Institute, National Institutes of Health
Adeyemo, Adebowale
National Human Genome Research Institute, National Institutes of Health
Collins, Francis
National Human Genome Research Institute, National Institutes of Health
Marshall , Patricia
National Human Genome Research Institute, National Institutes of Health
The H3A Diabetes Study: A multi-centre study of the prevalence and environmental and genetic determinants of type 2 diabetes in sub-Saharan Africa. (Field Data collection 2015-2018)
Africa Health Research Institute (AHRI)
2021
eng
1